Deerfield Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,000,000
Closed -$27.9M 163
2025
Q2
$27.6M Buy
+1,000,000
New +$26.3M 0.5% 41
2024
Q2
Sell
-2,337
Closed -$249K 522
2024
Q1
$249K Buy
+2,337
New +$236K ﹤0.01% 296

Other funds holding MRNA

Deerfield Management's MRNA Position: Q3 2025 in Review

Deerfield Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 1,000,000 shares — an estimated $27.9M sold.

Deerfield Management first reported a position in MRNA in Q1 2024 and held it in 2 quarters. The position peaked at $27.6M in Q2 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Deerfield Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 1,000,000 Moderna shares in Q3 2025, an estimated $27.9M.
  • Deerfield Management first reported a position in Moderna in Q1 2024 and held it in 2 quarters.
  • Deerfield Management's Moderna position peaked at $27.6M in Q2 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.